Abstract
The available approaches to the management of herpes simplex virus (HSV) infections currently consist primarily of chemotherapy and the possibility of preventive vaccination. In this review, we explore the potential of a third approach based on recent advances in molecular biology and genetic engineering which renders cells resistant to viral infection. This form of antiviral gene therapy, termed “intracellular immunization” by Baltimore (1988), involves the intracellular expression of a variety of molecular species specifically designed to inhibit targeted virus replication. The utility of such an approach lies in the direct application of knowledge pertaining to molecular mechanisms involved in viral pathogenesis to precisely interrupt lytic infection through the generation of virus-resistant cells. Such strategies may be particularly useful in the management of intracel-lular pathogens which are capable of evading the immune system or in circumstances in which knowledge of molecular pathogenic mechanisms far surpasses the ability to develop appropriate therapeutic drugs or vaccines. In this article, the basic concepts of intracellular immunization, relevant aspects of HSV molecular biology, and studies utilizing antiviral gene therapy to prevent HSV infection will be reviewed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen ND, Cran DG, Barton SC, Hettle S, Reik R, Surani MAH (1988) Transgenes as probes for active chromosomal domains in mouse development. Nature 333: 852–855
Anderson WF (1984) Prospects for human gene therapy. Science 226: 401–409
Andreason GL, Evans GA (1988) Introduction and expression of DNA moleculesin eukaryotic cells by electroporation. BioTechniques 6: 650–660
Anheiter H, Skuntz S, Noteborn M, Chang S, Meier E (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62: 51–61
Baltimore D (1988) Intracellular immunization. Nature 335: 395–396
Bass BL, Weintraub H (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55:1089–1098
Bednarik DP, Mosca JD, Raj NBK, Pitha PM (1989) Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha-2 interferon. Proc Natl Sci USA 86: 4958–4962
Benko DM, Robinson R, Solomin L, Mellini M, Felber BK, Pavlakis GN (1990) Binding of trans-dominant mutant rev protein of human immunodeficiency virus type 1 to the cis-acting rev-responsive element does not affect the fate of viral mRNA. New Biologist 2:1111–1122
Berns Kl, Bohenzky RA (1987) Adeno-associated viruses: an update. Adv Virus Res 32: 243–306
Berns Kl, Pinkerton TC, Thomas GF, Hoggan MD (1975) Detection of adeno-associated virus (AAV)-speeifie nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556–560
Bohnlein S, Pirker FP, Hofer L, Zimmermann K, Bachmayer H, Bohnlein E, Hauber J (1991) Trans-dominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol 65: 81–88
Breman JG, Arita I (1980) The confirmation and maintenance of smallpox eradication. N Engl J Med 303: 1263–1273
Buonocore L, Rose JK (1990) Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345: 625–628
Cameron FH, Jennings PA (1989) Specific gene suppression by engineered ribozymes in monkey cells. Proc Natl Acad Sci USA 86: 9139–9143
Cech TR (1988) Ribozymes and their medical implications. J Am Med Assoc 260: 3030–3034
Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55: 599–629
Chang L-J, Stoltzfus CM (1985) Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA. Mol Cell Biol 5: 2341–2348
Chang L-J, Stoltzfus CM (1987) Inhibition of Rous sarcoma virus replication by antisense RNA. J Virol 61:921–924
Chatterjee S, Rose JA, Johnson PR, Wong KK Jr (1991) Transduction of intracellular resistance to HIV production by an adeno-associated virus-based antisense vector. Vaccine 91: 85–90
Cohen EA, Gaudreau P, Brazeau P, Langelier Y (1986) Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2. Nature 321:441–443
Coleman J, Hirashima A, Inokuchi Y, Green PJ, Inouye M (1985) A novel immune system against bacteriophage infection using complementary RNA (micRNA). Nature 315: 601–603
Cotton M, Birnstiel ML (1989) Ribozyme mediated destruction of RNA in vivo. EMBO J 8: 3861–3866
Cukor G, Blacklow NR, Hoggan D, Berns Kl (1984) Biology of adeno-associated virus. In: Berns Kl (ed) The Parvoviruses. Plenum, New York, pp 33–66
Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagensis: integration of proviruses in a distinct chromosomal region. Cell 37:141–150
Dalgleish AG, Beverley PCI, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767
Domke I, Straub P, Kirchner H (1986) Effect of interferon on replication of herpes simplex virus type 1 and 2 in human macrophages. J Virol 60: 37–42
Dutia BM, Frame MC, Subak-Sharpe JH, Clark WN, Marsden HS (1986) Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides. Nature 321: 439–441
Eglitis MA, Anderson WF (1988) Retroviral vectors for introduction of genes into mammalian cells. BioTechniques 6: 608–614
Faraji-Shadan F, Stubbs JD, Bowman PD (1990) A putative approach for gene therapy against human immunodeficiency virus (HIV). Med Hypotheses 32: 81–84
Feng S, Holland EC (1988) HIV-1 tat trans-activation requires the loop sequence within tar. Nature 334: 165–167
Friedman AD, Triezenberg SJ, McKnight SL (1988) Expression of a truncated viral trans-activator selectively impedes lytic infection by its cognate virus. Nature 335: 452–454
Gao W-Y, Stein CA, Cohen JS, Dutschman GE, Cheng Y-C (1989) Effect of phosphorothioate homooligodeoxynucleotides on herpes simplex virus type 2 induced DNA polymerase. J Biol Chem 264:11521–11526
Gao W-Y, Hanes RN, Vazquez-Padua MA, Stein CA, Cohen JS, Cheng Y-C (1990) Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides. Antimicrob Agents Chemother 34: 808–812
Goldstein DJ, Weller SK (1988) Factor(s) present in herpes simpJex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology 166: 41–51
Goodchild J, Agrawal S, Civiera MP, Sarin PS, Sun D, Zamecnik PC (1988) Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 85: 5507–5511
Graham GJ, Maio JJ (1990) RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator. Proc. Natl Acad Sci USA 87: 5817–5821
Green M, Ishino M, Loewenstein PM (1989) Mutational analysis of HIV-1 tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58: 215–223
Green PJ, Pines O, Inouye M (1986) The role of antisense RNA in gene regulation. Annu Rev Biochem 55: 569–97
Gresser I (1986) Interferon-induced diseases. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II. Springer, Berlin Heidelberg New York, pp 232–242
Haigh A, Greaves R, O’Hare P (1990) Interference with the assembly of a virus-host transcription complex by peptide competition. Nature 334: 257–259
Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse al(l) collagen gene by blocking initiation of transcription. Nature 320: 365–367
Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585–591
Hayward WS, Neel BG, Astrin SM (1981) Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480
Helene C, Toulme J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049: 99–125
Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81: 6466–6470
Herskowitz I (1987) Functional inactivation of genes by dominant negative mutations. Nature 329: 219–222
Jenner E (1798) An inquiry into the causes and effects of the variolae vaccine, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of cowpox. Sampson Low, London
Jennings PD, Molloy PL (1987) Inhibition of SV40 replicon function by engineered antisense RNA transcribed by RNA polymerase III. EMBO J 10: 3043–3047
Johnson RM, Spear PG (1989) Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J Virol 63: 819–827
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768
Kotin RM, Berns Kl (1989) Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170: 460–467
Kotin RM, Siniscalco M, Samulski RJ, Zhu X, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns Kl (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211–2215
Kulka M, Smith CC, Aurelian L, Fishelevich R, Meade K, Miller P, Ts’o POP (1989) Site specificity of the inhibitory effects of oligo (nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci USA 86: 6868–6872
LaFace D, Hermonat P, Wakeland E, Peck A (1988) Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162: 483–486
Lebkowski JS, McNally MM, Okarma TB, Lerch LB (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996
Lisziewicz J, Rappaport J, Dhar R (1991) Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biologist 3: 82–89
Malim MH, Bohnlein S, Haubér J, Cullen BR (1989) Functional dissection of the HIV-1 rev trans-activator: derivation of a trans-dominant repressor of rev function. Cell 58: 205–214
Mavromara-Nazos P, Ackermann M, Roizman B (1986) Construction and properties of viable herpes simplex virus type 1 recombinant lacking coding sequences of the α47 gene. J Virol 60: 807–812
Mermer B, Felber BK, Campbell M, Pavlakis GN (1990) Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res 18: 2037–2044
Mannino RJ, Gould-Fogerite S (1988) Liposome mediated gene transfer. BioTechniques 6: 682–690
McClements W, Yamanaka G, Garsky V, Perry H, Bacchetti S, Colonno R, Stein RB (1988) Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation. Virology 162: 270–273
McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62:1963–1973
Miller AD (1990) Progress toward human gene therapy. Blood 76: 271–278
Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242
Miroshnichenko Ol, Ponomareva Tl, Tikchonenko Tl (1989) Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral Ela region. Gene 84: 83–89
Mittnacht S, Straub P, Kirschner H, Jacobsen H (1988) Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology 164: 201–210
Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF (1990) Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res Hum Retroviruses 6:183–191
Paradis H, Gaudreau P, Brazeau P, Langelier Y (1988) Mechanisms of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. J Biol Chem 263: 16045–16050
Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R (1990) A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat Proc Natl Acad Sci USA 87: 5079–5083
Post LE, Roizman B (1981) A generalized technique for deletion of specific genes in large genomes: a gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25: 227–232
Powell PA, Stark DM, Sanders PR, Beachy RN (1989) Protection against tobacco mosaic virus in transgenic plants that express tobacco mosaic virus antisense RNA. Proc Natl Acad Sci USA 86: 6949–6952
Prody GA, Bakos JT, Buzayan JM, Schneider IR, Bruening G (1986) Autolytic processing of dimeric plant virus satellite RNA. Science 231:1577–1580
Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689
Rhodes A, James W (1990) Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol 71:1965–1974
Rimsky L, Due Dodon M, Dixon EP, Greene WC (1989) Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I rex transactivator. Nature 341: 453–456
Salter DW, Crittenden LB (1989) Artificial insertion of a dominant gene for resistance to avian leukosis virus into the germ line of the chicken. Theor Appl Genet 77: 457–461
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Sarmiento M, Kleinerman ES (1990) Innate resistance to herpes simplex virus infection. Human lymphocyte and monocyte inhibition of viral replication. J Immunol 144(5): 1942–1953
Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA, Rossi JJ (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247:1222–1225
Sczakiel G, Pawlita M (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol 65: 468–472
Sears AE, Halliburton IW, Meignier B, Silver S, Roizman B (1985) Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells, and establishment of latency in mice. J Virol 55: 338–346
Seif I, de Maeyer E, Riviere I, de Maeyer-Guignard J (1991) Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment. J Virol 65: 664–671
Shepard AA, Polentino P, DeLuca NA (1990) Trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol 64: 3916–3926
Simons RW, Kleckner N (1988) Biological regulation by antisense RNA in prokaryotes. Annu Rev Genet 22: 567–601
Smith CC, Aurelian L, Reddy MP, Miller PS, Ts’o POP (1986) Antiviral effect olan oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc Natl Acad Sci 83: 2787–2791
Staeheli P (1990) Interferon-induced proteins and the antiviral state. Adv Virus Res 38: 147–200
Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C (1986) Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44: 147–158
Sullenger BA, Lee TC, Smith CA, Lingers GE, Gilboa E (1990a) Expression of chimeric tRNA-driven antisense transcripts renders NIH3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol 10: 6512–6523
Sullenger BA, Gallardo HF, Lingers GE, Gilboa E (1990b) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608
Tratschin JD, West MH, Sandbank T, Carter BJ (1984) A human parvovirus, adeno-associated virus, as a eukaryotic vector: transient expression and encapsidation of the prokaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4: 2072–2081
Trono D, Feinberg MB, Baltimore D (1989) HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59:113–120
Van der Krol AR, Lenting PE, Veenstra J, Van der Meer IM, Koes RE, Geräts AGM, Mol JNM, Stuitje AR (1988a) An anti-sense chalcone synthase gene in transgenic plants inhibits flower pigmentation. Nature 333: 866–869
Van der Krol AR, Mol JNM, Stuitje AR (1988b) Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. BioTechniques 6: 958–976
Von Rüden T, Gilboa E (1989) Inhibition of human T-cell leukemia virus type 1 replication in primary human T cells that express antisense RNA. J Virol 63: 677–682
Walder J (1988) Antisense DNA and RNA: progress and prospects. Genes Dev 2: 502–504
Weintraub H, Izant JG, Harland RM (1985) Anti-sense RNA as a molecular tool for genetic analysis. Trends Genet 2: 22–25
Werge TM, Biocca S, Cattaneo A (1990) Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. FEBS Lett 274:193–198
Whitley RJ (1990) Herpes simplex viruses. In: Fields BN, Knipe DM et al. Virology, 2nd edn. Raven, New York, pp 1843–1887
Wong KK Jr, Rose JA, Chatterjee S (1991) Restriction of HSV-1 production in cell lines transduced with an antisense viral vector targeting the ICP4 gene. In: Vaccine 91. Cold Spring Harbor Laboratory Press, New York, pp 183–189
Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transfor-mation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75: 280–284
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin, Heidelberg
About this chapter
Cite this chapter
Wong, K.K., Chatterjee, S. (1992). Controlling Herpes Simplex Virus Infections: is Intracellular Immunization the Way of the Future?. In: Rouse, B.T. (eds) Herpes Simplex Virus. Current Topics in Microbiology and Immunology, vol 179. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77247-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-77247-4_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77249-8
Online ISBN: 978-3-642-77247-4
eBook Packages: Springer Book Archive